Skip to main content
ConductScienceScienceDex

Joe G. N. Garcia

NIH Rank #2558
Unclaimed recordClaim profile
  • Program Leader
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1862824Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2024

Linked Award Amount
$3M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#2,558
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Joe G. N. Garcia. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Joe G. N. Garcia as a PI. Multi-PI records show the full award amount for context.

  • 5R42DK135208-03R42
    Targeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity
    Aqualung Therapeutics Corp.
    $975.2K
    award amount
  • 5R44HL145930-05R44
    A Randomized Phase 2A Clinical Trial Pioneering the Utility of an eNAMPT-Reducing Therapy in ARDS/VILI: the PUERTA Trial
    Aqualung Therapeutics Corp.
    $957.6K
    award amount
  • 5R42HL164300-03R42
    Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension
    Aqualung Therapeutics Corp.
    $809K
    award amount
  • 5P01HL126609-08P01
    Cytoskeletal Regulation of Lung Endothelial Pathobiology in ARDS
    University of Florida
    $294.5K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Joe G. N. Garcia as a PI.

Aqualung Therapeutics Corp.
FL
$2.7M
3 grants
University of Florida
FL
$294.5K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Aqualung Therapeutics Corp.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2558
  6. 2024
    Entered Top 25% Nationally
    Ranked #2558
  7. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  8. 2025
    Program/Center Grant Leader
  9. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Joe G. N. Garcia.

Anne E Cress
University of Florida
2
shared awards
Ayako Makino
University of Florida
2
shared awards
Carol C Gregorio
University of Florida
2
shared awards
Nathan A. Ellis
University of Florida
2
shared awards
Saad Sammani
University of Florida
2
shared awards
Steven M Dudek
University of Florida
2
shared awards
Brian Michael Luna
University of Florida
1
shared award
Jurgen Bernd Bulitta
University of Florida
1
shared award

Explore further

Find collaborators for Joe G. N. Garcia

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →